Literature DB >> 21750207

Provision of balanced nutrition protects against hypoglycemia in the critically ill surgical patient.

Rondi M Kauffmann1, Rachel M Hayes, Judith M Jenkins, Patrick R Norris, Jose J Diaz, Addison K May, Bryan R Collier.   

Abstract

BACKGROUND: Intensive insulin therapy lowers blood glucose and improves outcomes but increases the risk of hypoglycemia. Typically, insulin protocols require a dextrose solution to prevent hypoglycemia. The authors hypothesized that the provision of balanced nutrition (enteral nutrition [EN] or parenteral nutrition [PN]) would be more protective against hypoglycemia (≤50 mg/dL) than carbohydrate alone.
METHODS: A retrospective analysis was performed of patients treated with intensive insulin therapy and surviving ≥24 hours. The computer-based insulin protocol requires infusion of D10W at 30 mL/h if EN or PN is not provided. Nutrition provision was assessed in 2-hour increments, comparing periods of blood glucose control with and without balanced nutrition. The risk of hypoglycemia for each blood glucose measurement was estimated by multivariable regression.
RESULTS: In total, 66,592 glucose measurements were collected on 1392 patients. Hypoglycemic events occurred in 5.8/1000 glucose tests after 2 hours without balanced nutrition compared to 2.2/1000 tests when balanced nutrition was given in the preceding 2 hours. In multivariable regression models, balanced nutrition was the strongest protective factor against hypoglycemia. Patients who did not receive balanced nutrition in the preceding 2 hours had a 3 times increase in the odds of a hypoglycemic event at their next glucose check (odds ratio = 3.6, P < .001). Providing carbohydrate alone was not protective.
CONCLUSIONS: Balanced nutrition is associated with reduced risk of hypoglycemia. These results suggest that balanced nutrition should be given when insulin therapy is initiated. Future studies should evaluate the efficacy of EN vs PN in preventing hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21750207      PMCID: PMC3985398          DOI: 10.1177/0148607111413904

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  38 in total

Review 1.  Stress hyperglycaemia.

Authors:  Kathleen M Dungan; Susan S Braithwaite; Jean-Charles Preiser
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

2.  Intensive versus conventional glucose control in critically ill patients.

Authors:  Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

3.  Intensive insulin therapy in practice: can we do it?

Authors:  Lesly A Dossett; Bryan Collier; Rafe Donahue; Nathan T Mowery; Marcus J Dortch; Oscar Guillamondegui; Jose J Diaz; Addison K May
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008-10-02       Impact factor: 4.016

4.  Designing and implementing insulin infusion protocols and order sets.

Authors:  Andrew J Ahmann; Greg Maynard
Journal:  J Hosp Med       Date:  2008-09       Impact factor: 2.960

Review 5.  Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)--a review of recent literature.

Authors:  Corey Scurlock; Jayashree Raikhelkar; Jeffrey I Mechanick
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-03       Impact factor: 4.294

6.  Blood glucose concentration and outcome of critical illness: the impact of diabetes.

Authors:  Moritoki Egi; Rinaldo Bellomo; Edward Stachowski; Craig J French; Graeme K Hart; Colin Hegarty; Michael Bailey
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

7.  Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality.

Authors:  Yaseen M Arabi; Hani M Tamim; Asgar H Rishu
Journal:  Crit Care Med       Date:  2009-09       Impact factor: 7.598

Review 8.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.

Authors:  Donald E G Griesdale; Russell J de Souza; Rob M van Dam; Daren K Heyland; Deborah J Cook; Atul Malhotra; Rupinder Dhaliwal; William R Henderson; Dean R Chittock; Simon Finfer; Daniel Talmor
Journal:  CMAJ       Date:  2009-03-24       Impact factor: 8.262

9.  Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.

Authors:  Mikhail Kosiborod; Silvio E Inzucchi; Abhinav Goyal; Harlan M Krumholz; Frederick A Masoudi; Lan Xiao; John A Spertus
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

Review 10.  Clinical benefits of tight glycaemic control: focus on the perioperative setting.

Authors:  Anthony P Furnary
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2009-12
View more
  3 in total

1.  Hypocaloric enteral nutrition protects against hypoglycemia associated with intensive insulin therapy better than intravenous dextrose.

Authors:  Rondi M Kauffmann; Rachel M Hayes; Amanda H VanLaeken; Patrick R Norris; Jose J Diaz; Addison K May; Bryan R Collier
Journal:  Am Surg       Date:  2014-11       Impact factor: 0.688

2.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Authors:  Andrew Rhodes; Laura E Evans; Waleed Alhazzani; Mitchell M Levy; Massimo Antonelli; Ricard Ferrer; Anand Kumar; Jonathan E Sevransky; Charles L Sprung; Mark E Nunnally; Bram Rochwerg; Gordon D Rubenfeld; Derek C Angus; Djillali Annane; Richard J Beale; Geoffrey J Bellinghan; Gordon R Bernard; Jean-Daniel Chiche; Craig Coopersmith; Daniel P De Backer; Craig J French; Seitaro Fujishima; Herwig Gerlach; Jorge Luis Hidalgo; Steven M Hollenberg; Alan E Jones; Dilip R Karnad; Ruth M Kleinpell; Younsuk Koh; Thiago Costa Lisboa; Flavia R Machado; John J Marini; John C Marshall; John E Mazuski; Lauralyn A McIntyre; Anthony S McLean; Sangeeta Mehta; Rui P Moreno; John Myburgh; Paolo Navalesi; Osamu Nishida; Tiffany M Osborn; Anders Perner; Colleen M Plunkett; Marco Ranieri; Christa A Schorr; Maureen A Seckel; Christopher W Seymour; Lisa Shieh; Khalid A Shukri; Steven Q Simpson; Mervyn Singer; B Taylor Thompson; Sean R Townsend; Thomas Van der Poll; Jean-Louis Vincent; W Joost Wiersinga; Janice L Zimmerman; R Phillip Dellinger
Journal:  Intensive Care Med       Date:  2017-01-18       Impact factor: 17.440

3.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.